Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Investing Activities (2018 - 2025)

Organogenesis Holdings (ORGO) has 8 years of Cash from Investing Activities data on record, last reported at -$4.7 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 38.41% year-over-year to -$4.7 million; the TTM value through Dec 2025 reached -$14.2 million, down 41.06%, while the annual FY2025 figure was -$14.2 million, 41.06% down from the prior year.
  • Cash from Investing Activities reached -$4.7 million in Q4 2025 per ORGO's latest filing, down from -$2.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1.9 million in Q2 2024 and bottomed at -$16.7 million in Q3 2021.
  • Average Cash from Investing Activities over 5 years is -$5.7 million, with a median of -$4.8 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: crashed 131.09% in 2021, then soared 74.93% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$5.2 million in 2021, then plummeted by 103.86% to -$10.7 million in 2022, then surged by 68.81% to -$3.3 million in 2023, then dropped by 1.11% to -$3.4 million in 2024, then crashed by 38.41% to -$4.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$4.7 million in Q4 2025, -$2.2 million in Q3 2025, and -$3.6 million in Q2 2025.